Literature DB >> 15509898

Prenatal cannabinoid exposure down- regulates glutamate transporter expressions (GLAST and EAAC1) in the rat cerebellum.

I Suárez1, G Bodega, M Rubio, J J Fernández-Ruiz, J A Ramos, B Fernández.   

Abstract

Efficient reuptake of synaptically released glutamate is essential for preventing glutamate receptor overstimulation and neuronal death. Glutamate transporters play a vital role in removing extracellular glutamate from the synaptic cleft. This study analyzed the expression of the glial (GLAST) and neuronal (EAAC1) subtypes of glutamate transporter in the cerebellum of male and female offspring exposed pre- and postnatally to Delta9-tetrahydrocannabinol (THC, the main component of marijuana). Pregnant rats were administered saline or THC from gestational day 5 to postnatal day 20 (PD20). The expression of glutamate transporters was examined at PD20, PD30 and PD70 (10 and 50 days after THC withdrawal) to analyze the short- and long-term effects of prenatal THC exposure. The expression of the glutamate transporter GLAST in astroglial cells and EAAC1 in Purkinje neurons decreased in THC-exposed offspring compared to controls. This reduction was observed at all ages but mainly in males. Moreover, the glial glutamate transporter level in THC-exposed rats (quantified by Western blot) was lower than in control rats. These results suggest that THC exposure during cerebellar development may alter the glutamatergic system not only during the period of drug exposure but in the postnatal stage following withdrawal. The down-regulation reported here might reflect an abnormal maturation of the glutamatergic neuron-glia circuitry. 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509898     DOI: 10.1159/000080711

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  6 in total

Review 1.  Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Authors:  Didier Jutras-Aswad; Jennifer A DiNieri; Tibor Harkany; Yasmin L Hurd
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-02       Impact factor: 5.270

Review 2.  Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Authors:  Elizabeth E Zumbrun; Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-25       Impact factor: 4.147

Review 3.  Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.

Authors:  Luca Ferraro; M C Tomasini; S Beggiato; S Gaetani; T Cassano; V Cuomo; S Amoroso; S Tanganelli; T Antonelli
Journal:  J Neural Transm (Vienna)       Date:  2009-05-12       Impact factor: 3.575

4.  Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling.

Authors:  Rongqing Chen; Jian Zhang; Ni Fan; Zhao-Qian Teng; Yan Wu; Hongwei Yang; Ya-Ping Tang; Hao Sun; Yunping Song; Chu Chen
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

Review 5.  Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse.

Authors:  Sade Spencer; Peter W Kalivas
Journal:  Int J Neuropsychopharmacol       Date:  2017-10-01       Impact factor: 5.176

Review 6.  The epigenetic legacy of illicit drugs: developmental exposures and late-life phenotypes.

Authors:  Nicole M Wanner; Mathia L Colwell; Christopher Faulk
Journal:  Environ Epigenet       Date:  2019-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.